Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study

被引：0
|
作者：
Ohoud Aljuhani
Khalid Al Sulaiman
Adel Alshabasy
Khalid Eljaaly
Abdulrahman I. Al Shaya
Haytham Noureldeen
Mohammed Aboudeif
Bodoor Al Dosari
Amina Alkhalaf
Ghazwa B. Korayem
Muneera M. Aleissa
Hisham A. Badreldin
Shmeylan Al Harbi
Abdullah Alhammad
Ramesh Vishwakarma
机构：
[1] King Abdulaziz University,Department of Pharmacy Practice, Faculty of Pharmacy
[2] King Abdulaziz Medical City,Pharmaceutical Care Department
[3] King Abdulaziz University,Department of Anesthesia and Intensive Care
[4] King Saud Bin Abdulaziz University for Health Sciences,College of Pharmacy
[5] King Abdullah International Medical Research Center,Pharmaceutical Care Department
[6] King Abdulaziz University Hospital,College of Pharmacy
[7] Princess Nourah Bint Abdulrahman University,Department of Clinical Pharmacy, College of Pharmacy
[8] King Saud University,College of Pharmacy
[9] University of Arizona,Department of Anesthesia and Intensive Care
[10] Brigham and Women’s Hospital,undefined
[11] Ain Shams University,undefined
来源：
BMC Infectious Diseases | / 21卷
关键词：
COVID-19; SARS-Cov-2; Tocilizumab; Secondary infection; CRE; Critically ill; Intensive care units (ICUs); Immunomodulatory drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Association between Pulmonary Aspergillosis and Cytomegalovirus Reactivation in Critically Ill COVID-19 Patients: A Prospective Observational Cohort Study
    Caciagli, Valeria
    Coloretti, Irene
    Talamonti, Marta
    Farinelli, Carlotta
    Gatto, Ilenia
    Biagioni, Emanuela
    Sarti, Mario
    Franceschini, Erica
    Meschiari, Marianna
    Mussini, Cristina
    Tonelli, Roberto
    Clini, Enrico
    Girardis, Massimo
    Busani, Stefano
    VIRUSES-BASEL, 2023, 15 (11):
  • [32] Rhabdomyolysis in Critically Ill Patients With COVID-19: A Retrospective Study
    Nashwan, Abdulqadir J.
    Alassaf, Anood
    Abujaber, Ahmad A.
    Al Wraidat, Mohammad
    Ananthegowda, Dore C.
    Al-Kaabi, Salma K.
    Othman, Muftah
    Ahmad, Muayad K.
    Al Maslamani, Muna
    Khatib, Mohamad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [33] Safety and efficacy of tocilizumab in critically ill patients with COVID-19: an observational study
    Youssef, Ghada A.
    Wagih, Khalid M.
    Hamid, Hossam M. Abdel
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2023, 17 (01)
  • [34] Safety and efficacy of tocilizumab in critically ill patients with COVID-19: an observational study
    Ghada A. Youssef
    Khalid M. Wagih
    Hossam M. Abdel Hamid
    The Egyptian Journal of Bronchology, 17
  • [35] Efficacy of Tocilizumab in Management of COVID-19 Patients Admitted to Intensive Care Units: A Multicenter Retrospective Cohort Study
    Ibrahem, Hoda Younes
    Aly, Doaa Hamdy
    Warda, Ahmed E. Abou
    Farahat, Ramadan Abdelmoez
    Youssef, Raghda Mamdouh
    Abdelhamid, Mona Hassan
    Goud, Heba Ahmed
    Mohamed, Rana Ragab
    Eldien, Menna Allah Y. Nasr
    Alotaibi, Fahad Obaid
    Alzarea, Abdulaziz Ibrahim
    Alanazi, Abdullah Salah
    Eisa, Nehal M.
    Refaee, Abdelrahman S. H.
    MEDICINA-LITHUANIA, 2023, 59 (01):
  • [36] Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study
    Chilimuri, Sridhar
    Sun, Haozhe
    Alemam, Ahmed
    Kang, Kyoung-Sil
    Lao, Peter
    Mantri, Nikhitha
    Schiller, Lawrence
    Sharabun, Myroslava
    Shehi, Elona
    Tejada, Jairo
    Yugay, Alla
    Nayudu, Suresh Kumar
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 440 - 446
  • [37] Predictors of COVID-19 Mortality in Critically Ill ICU Patients: A Multicenter Retrospective Observational Study
    Umeh, Chukwuemeka
    Tuscher, Laura
    Ranchithan, Sobiga
    Watanabe, Kimberly
    Gupta, Rahul
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [38] Tocilizumab is associated with reduced delirium and coma in critically ill patients with COVID-19
    Alkhateeb, Tuqa
    Stollings, Joanna L.
    Sohn, Ine
    Liu, Dandan
    Fleenor, L. Montana
    Ely, E. Wesley
    Lahiri, Shouri
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [39] Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?
    Camou, Fabrice
    Issa, Nahema
    Hessamfar, Mojgan
    Guisset, Olivier
    Mourissoux, Gaelle
    Pedeboscq, Stephane
    Minot, Aimee
    Bonnet, Fabrice
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [40] Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study
    Al Sulaiman, Khalid A.
    Aljuhani, Ohoud
    Eljaaly, Khalid
    Alharbi, Aisha A.
    Al Shabasy, Adel M.
    Alsaeedi, Alawi S.
    Al Mutairi, Mashael
    Badreldin, Hisham A.
    Al Harbi, Shmeylan A.
    Al Haji, Hussain A.
    Al Zumai, Omar, I
    Vishwakarma, Ramesh K.
    Alkatheri, Abdulmalik
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 180 - 187
12345